Katarzyna Parzych

491 total citations
7 papers, 233 citations indexed

About

Katarzyna Parzych is a scholar working on Epidemiology, Molecular Biology and Cell Biology. According to data from OpenAlex, Katarzyna Parzych has authored 7 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Molecular Biology and 3 papers in Cell Biology. Recurrent topics in Katarzyna Parzych's work include Autophagy in Disease and Therapy (3 papers), Endoplasmic Reticulum Stress and Disease (3 papers) and interferon and immune responses (2 papers). Katarzyna Parzych is often cited by papers focused on Autophagy in Disease and Therapy (3 papers), Endoplasmic Reticulum Stress and Disease (3 papers) and interferon and immune responses (2 papers). Katarzyna Parzych collaborates with scholars based in United Kingdom, United States and France. Katarzyna Parzych's co-authors include William R. H. Wright, Mark J. Paul‐Clark, Jane A. Mitchell, Holger W. Auner, Nicholas S. Kirkby, Anna V. Zetterqvist, Charles A. Mein, Maciej Kaliszczak, Eric O. Aboagye and Yunqing Li and has published in prestigious journals such as PLoS ONE, Biomaterials and Oncogene.

In The Last Decade

Katarzyna Parzych

7 papers receiving 225 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katarzyna Parzych United Kingdom 7 135 48 45 39 34 7 233
Liliana Pâslaru Romania 12 156 1.2× 35 0.7× 21 0.5× 43 1.1× 48 1.4× 32 313
Jisun Kim United States 7 187 1.4× 70 1.5× 48 1.1× 37 0.9× 17 0.5× 11 264
Katharina Baebler Switzerland 7 94 0.7× 32 0.7× 29 0.6× 19 0.5× 30 0.9× 10 188
Beate Vollenbröker Germany 10 171 1.3× 16 0.3× 27 0.6× 127 3.3× 32 0.9× 15 374
Melanie Heinlein Australia 7 166 1.2× 114 2.4× 64 1.4× 24 0.6× 37 1.1× 9 295
Gamze Bildik Türkiye 13 156 1.2× 38 0.8× 74 1.6× 31 0.8× 54 1.6× 30 523
Julia M. Scheffler Sweden 10 153 1.1× 28 0.6× 95 2.1× 84 2.2× 18 0.5× 20 338
Valérie Senée France 11 270 2.0× 27 0.6× 41 0.9× 89 2.3× 10 0.3× 13 600
Irene Miguel-Escalada United Kingdom 8 209 1.5× 35 0.7× 16 0.4× 25 0.6× 16 0.5× 21 361
Michael O’Hare United Kingdom 10 86 0.6× 33 0.7× 26 0.6× 17 0.4× 15 0.4× 16 229

Countries citing papers authored by Katarzyna Parzych

Since Specialization
Citations

This map shows the geographic impact of Katarzyna Parzych's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katarzyna Parzych with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katarzyna Parzych more than expected).

Fields of papers citing papers by Katarzyna Parzych

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katarzyna Parzych. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katarzyna Parzych. The network helps show where Katarzyna Parzych may publish in the future.

Co-authorship network of co-authors of Katarzyna Parzych

This figure shows the co-authorship network connecting the top 25 collaborators of Katarzyna Parzych. A scholar is included among the top collaborators of Katarzyna Parzych based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katarzyna Parzych. Katarzyna Parzych is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Parzych, Katarzyna, Paula Saavedra-García, Gabriel N. Valbuena, et al.. (2019). The coordinated action of VCP/p97 and GCN2 regulates cancer cell metabolism and proteostasis during nutrient limitation. Oncogene. 38(17). 3216–3231. 33 indexed citations
2.
Kaliszczak, Maciej, et al.. (2018). The HDAC6 inhibitor C1A modulates autophagy substrates in diverse cancer cells and induces cell death. British Journal of Cancer. 119(10). 1278–1287. 38 indexed citations
3.
Loaiza, Sandra, Sílvia A. Ferreira, Elena Tsolaki, et al.. (2018). An engineered, quantifiable in vitro model for analysing the effect of proteostasis-targeting drugs on tissue physical properties. Biomaterials. 183. 102–113. 9 indexed citations
4.
Parzych, Katarzyna, Anna V. Zetterqvist, William R. H. Wright, et al.. (2017). Differential role of pannexin‐1/ATP/ P2X 7 axis in IL‐1β release by human monocytes. The FASEB Journal. 31(6). 2439–2445. 52 indexed citations
5.
Parzych, Katarzyna, Zhangwei Chen, Florentina Porsch, et al.. (2015). Inadequate fine-tuning of protein synthesis and failure of amino acid homeostasis following inhibition of the ATPase VCP/p97. Cell Death and Disease. 6(12). e2031–e2031. 27 indexed citations
6.
Paul‐Clark, Mark J., Peter M. George, Timothy Gatheral, et al.. (2012). Pharmacology and therapeutic potential of pattern recognition receptors. Pharmacology & Therapeutics. 135(2). 200–215. 32 indexed citations
7.
Wright, William R. H., et al.. (2012). Inflammatory Transcriptome Profiling of Human Monocytes Exposed Acutely to Cigarette Smoke. PLoS ONE. 7(2). e30120–e30120. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026